Kidney disease targets and uses thereof
AssigneeCelera Corporation
InventorsElizabeth G. Joseloff, Yeoun Jin Kim, Tao He, Steve Ruben
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
Claims5
A method of diagnosing kidney cancer in a subject suspected of having kidney cancer, the method comprising detecting a level of LAMP1 protein in a sample from the subject, wherein a higher level of LAMP1 protein in said sample as compared to the level of LAMP1 protein in normal samples indicates that said subject has kidney cancer.
Dependencies are inferred from the claim text.